Seguir
Dr. Juan Pablo Maianti
Dr. Juan Pablo Maianti
E-mail confirmado em fas.harvard.edu
Título
Citado por
Citado por
Ano
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
LW Koblan, JL Doman, C Wilson, JM Levy, T Tay, GA Newby, JP Maianti, ...
Nature biotechnology 36 (9), 843-846, 2018
7722018
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
JP Maianti, A McFedries, ZH Foda, RE Kleiner, XQ Du, MA Leissring, ...
Nature 511 (7507), 94-98, 2014
2702014
Second-generation DNA-templated macrocycle libraries for the discovery of bioactive small molecules
DL Usanov, AI Chan, JP Maianti, DR Liu
Nature chemistry 10 (7), 704-714, 2018
1572018
Editing of CCR5 receptor gene to protect against HIV infection
JP Maianti, DR Liu
US Patent 10,745,677, 2020
432020
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
JP Maianti, GA Tan, A Vetere, AJ Welsh, BK Wagner, MA Seeliger, DR Liu
Nature chemical biology 15 (6), 565-574, 2019
412019
Gene editing of pcsk9
JP Maianti, DR Liu
US Patent App. 15/852,526, 2018
412018
Incorporation of unnatural amino acids into proteins using base editing
JP Maianti, DR Liu, LW Koblan
US Patent 11,542,509, 2023
292023
Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
DR Liu, JP Maianti, A Saghatelian, RE Kleiner
US Patent 9,243,038, 2016
282016
Hybrid Aminoglycoside Antibiotics via Tsuji Palladium-Catalyzed Allylic Deoxygenation
S Hanessian, JP Maianti, RD Matias, LA Feeney, ES Armstrong
Organic letters 13 (24), 6476-6479, 2011
282011
Synthesis and Comparative Antibacterial Activity of Verdamicin C2 and C2a. A New Oxidation of Primary Allylic Azides in Dihydro[2H]pyrans
S Hanessian, J Szychowski, JP Maianti
Organic letters 11 (2), 429-432, 2009
282009
Editing of CCR2 receptor gene to protect against HIV infection
JP Maianti, DR Liu
US Patent 11,820,969, 2023
232023
Synthesis, broad spectrum antibacterial activity, and X-ray co-crystal structure of the decoding bacterial ribosomal A-site with 4′-deoxy-4′-fluoro neomycin analogs
S Hanessian, OM Saavedra, MA Vilchis-Reyes, JP Maianti, H Kanazawa, ...
Chemical Science 5 (12), 4621-4632, 2014
232014
Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogs
JP Maianti, H Kanazawa, P Dozzo, RD Matias, LA Feeney, ES Armstrong, ...
ACS chemical biology 9 (9), 2067-2073, 2014
222014
Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue
S Hanessian, A Giguere, J Grzyb, JP Maianti, OM Saavedra, JB Aggen, ...
ACS Medicinal Chemistry Letters 2 (12), 924-928, 2011
222011
Antibacterial aminoglycoside analogs
JB Aggen, AA Goldblum, DJ Hildebrandt, TR Kane, P Dozzo, MJ Gliedt, ...
US Patent 8,399,419, 2013
212013
Suppression of pain by gene editing
JP Maianti, DR Liu
US Patent 11,898,179, 2024
192024
The fungicide Mancozeb induces metacaspase-dependent apoptotic cell death in Saccharomyces cerevisiae BY4741
FJ Scariot, LM Jahn, JP Maianti, APL Delamare, S Echeverrigaray
Apoptosis 21, 866-872, 2016
192016
Cancer vaccine
JP Maianti, DR Liu
US Patent App. 16/492,534, 2021
182021
Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
DR Liu, JP Maianti, A Saghatelian, RE Kleiner
US Patent 9,610,322, 2017
182017
Structural hybridization of three aminoglycoside antibiotics yields a potent broad-spectrum bactericide that eludes bacterial resistance enzymes
JP Maianti, S Hanessian
MedChemComm 7 (1), 170-176, 2016
172016
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20